Monivent AB — Investor Relations & Filings

Monivent AB is a medical technology company focused on improving respiratory support for newborn babies. The company develops solutions to address the risks associated with manual ventilation at birth, where improper air volume can cause serious lung and brain damage. Its main product, the Monivent Neo100, is a non-invasive monitoring device that provides real-time feedback on critical ventilation parameters directly in the face mask. This enables caregivers to deliver more precise and gentle ventilation based on objective data rather than clinical experience alone, enhancing patient safety. The company also offers the Monivent Neo Training system for simulation-based education to improve manual ventilation skills.